Page 80 - 南京医科大学自然版
P. 80

第46卷第6期
               ·862  ·                           南 京    医 科 大 学 学         报                        2026年6月


              测模型仅在初始队列中进行了性能评估,尚缺乏                                  landscape in pediatric immune thrombocytopenia:ad⁃
              验证。因此,未来仍需通过大样本、多中心的前瞻                                 dressing unmet needs[J]. Pediatr Blood Cancer,2025,72
              性研究,并采用 Bootstrap 重抽样等技术进行严格                          (7):e31758
              的内部验证,以评估模型的校准度和区分度的稳                             [6] ROSU V E,ROSU S T,IVANOV A V,et al. Predictor fac⁃
                                                                     tors for chronicity in immune thrombocytopenic Purpura
              定性;同时,应在独立的外部队列中进行验证,以
                                                                     in children[J]. Children(Basel),2023,10(6):911
              进一步确认预测模型的普适性与临床价值。此
                                                                [7] PINCEZ T,FERNANDES H,PASQUET M,et al. Impact
              外,本研究主要聚焦于临床指标,尚未深入探讨性
                                                                     of age at diagnosis,sex,and immunopathological manifes⁃
              别差异背后的免疫学机制。后续研究可结合淋巴                                  tations in 886 patients with pediatric chronic immune
              细胞亚群、细胞因子谱等免疫学指标,从机制层面                                 thrombocytopenia[J]. Am J Hematol,2023,98(6):857-
              深入阐释性别因素在 ITP 慢性化中的作用,为精准                              868
              风险分层和设计性别特异性治疗策略提供更有力                             [8] 任   颖,谢    萍. 儿童免疫性血小板减少症临床特征分
              的证据。                                                   析[J]. 中国实验血液学杂志,2023,31(5):1443-1447
                  利益冲突声明:                                            REN Y,XIE P. Clinical characteristics analysis of im⁃
                  所有作者声明无利益冲突。                                       mune thrombocytopenia in children[J]. Journal of Experi⁃
                  Conflict of Interests:                             mental Hematology,2023,31(5):1443-1447
                                                                [9] BU S Y,LIU M,YANG L,et al. The function of T cells in
                  All authors declare no conflict of interests.
                                                                     immune thrombocytopenia[J]. Front Immunol,2025,16:
                  作者贡献声明:
                  薛园园负责设计研究方案,手稿撰写;张荣荣、田兆方、                          1499014
              赵继鸥负责文章审阅及修订;徐蔚,梁冬梅负责数据分析和                        [10]GEORGI J A,MIDDEKE J M,BORNHÄUSER M,et al.
              处理;袁玉芳指导研究方向选定,负责论文审阅和修改。                              Deciphering the genetic basis of immune thrombocytope⁃
                  Author’s Contributions:                            nia:current evidence for genetic predisposition in adult
                  XUE Yuanyuan was responsible for designing the study,  ITP[J]. Blood Adv,2023,7(14):3710-3724
              drafting the manuscript;ZHANG Rongrong,TIAN Zhaofang,  [11]DAVID P,SANTOS G M,PATT Y S,et al. Immune throm⁃
                                                                     bocytopenia(ITP)⁃ could it be part of autoimmune/inflam⁃
              and ZHAO Ji’ou were responsible for reviewing and revising the
                                                                     matory syndrome induced by adjuvants(ASIA)?[J]. Auto⁃
              manuscript;XU Wei and LIANG Dongmei were responsible for
                                                                     immun Rev,2024,23(9):103605
              data analysis and processing;YUAN Yufang provided guidance
                                                                [12]YAZDANBAKHSH K,PROVAN D,SEMPLE J W. The
              on research direction selection and was responsible for paper re⁃
                                                                     role of T cells and myeloid⁃derived suppressor cells in re⁃
              view and revision.
                                                                     fractory immune thrombocytopenia[J]. Br J Haematol,
             [参考文献]
                                                                     2023,203(1):54-61
             [1] RODEGHIERO F,STASI R,GERNSHEIMER T,et al.      [13]DODD K C,MENON M. Sex bias in lymphocytes:implica⁃
                   Standardization of terminology,definitions and outcome  tions for autoimmune diseases[J]. Front Immunol,2022,
                   criteria in immune thrombocytopenic purpura of adults and  13:945762
                   children:report from an international working group[J].  [14]中国儿童原发性免疫性血小板减少症诊断与治疗指南
                   Blood,2009,113(11):2386-2393                      改编工作组,中华医学会儿科学分会血液学组,中华儿
             [2] SCHMIDT D E,WENDTLAND E P,HEITINK⁃POLLÉ K           科杂志编辑委员会. 中国儿童原发性免疫性血小板减
                   M J,et al. A clinical prediction score for transient versus  少症诊断与治疗改编指南(2021 版)[J]. 中华儿科杂
                   persistent childhood immune thrombocytopenia[J]. J  志,2021,59(10):810-819
                   Thromb Haemost,2021,19(1):121-130                 Working Group of Chinese Guideline for the Diagnosis
             [3] KAPUR R. Intravenous immunoglobulins ameliorate throm⁃  and Treatment of Childhood Primary Immune Thrombocy⁃
                   bin⁃related platelet functions in childhood immune throm⁃  topenia;the Subspecialty Group of Hematologic Diseases,
                   bocytopenia[J]. Br J Haematol,2023,201(6):1019-   the Society of Pediatrics,Chinese Medical Association;
                   1020                                              the Editorial Board,Chinese Journal of Pediatrics. Adapt⁃
             [4] WANG Y T,TANG Y Q,MA J Y,et al. Contrastive learn⁃  ed guideline for the diagnosis and treatment of primary im⁃
                   ing with transformer to predict the chronicity of children  mune thrombocytopenia for Chinese children(2021)[J].
                   with immune thrombocytopenia[J]. IEEE J Biomed    Chinese Journal of Pediatrics,2021,59(10):810-819
                   Health Inform,2025,29(7):5229-5242           [15]FERNÁNDEZ ⁃ PLAZA S,GONZÁLEZ DE PABLO J,
             [5] AZEVEDO J,DIRAIMO J,NEUNERT C,et al. Treatment      GÁLVEZ E,et al. Variables related to chronic immune
   75   76   77   78   79   80   81   82   83   84   85